AMTI — Applied Molecular Transport. Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Applied Molecular Transport Announces Top-Line Phase 2 Results From Market Combination Trial Of Oral AMT-101
Brief: Applied Molecular To Report Top-Line Phase 2 Results From Market Combination Trial Of Oral AMT-101 In Patients With Moderate-To-Severe Ulcerative Colitis
U.S. RESEARCH ROUNDUP-Coupa Software, Diversey Holdings, Dow
Applied Molecular falls after shelving early-stage drugs
Brief: Applied Molecular Transport Inc. - Implements Cost Reductions To Support Strategic Prioritization And Extend Estimated Cash Runway Into 2024
Brief: Applied Molecular Estimates It Will Incur $3.5 Mln-$4.5 Mln In Costs Primarily Related To Severance Costs And Related Expenses
Applied Molecular Transport Inc. reports results for the quarter ended in March - Earnings Summary
U.S. RESEARCH ROUNDUP- Applied Blockchain, Cheniere Energy, Roblox
Applied Molecular Transport Inc. expected to post a loss of 75 cents a share - Earnings Preview
Brief: Applied Molecular Reports Results from Trial of AMT-101 in Patients with Chronic Pouchitis
Brief: Applied Molecular Transport Files For Mixed Shelf Of Up To $150 Mln
Brief: Applied Molecular Transport Reports Q4 And Full Year 2021 Results
Brief: Applied Molecular Transport Says May Offer And Sell Shares Of Common Stock Of Up To $150 Million From Time To Time
Brief: Applied Molecular Transport Announces Board Appointments
Applied Molecular Transport Inc. reports results for the quarter ended in September - Earnings Summary
Brief: Applied Molecular Transport Posts Quarterly Loss Per Share Of $0.68
Applied Molecular Transport Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Applied Molecular Transport Appoints Holly Schachner To Its Board Of Directors
Applied Molecular Transport Inc. reports results for the quarter ended in June - Earnings Summary